Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy
This randomized phase III trial studies radiation therapy with chemotherapy to see how well
it works compared to radiation therapy alone in treating patients with stage I or stage II
cervical cancer who previously underwent surgery. Radiation therapy uses high-energy x-rays
to kill tumor cells. Drugs used in chemotherapy, such as cisplatin, work in different ways
to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. It is not yet known whether giving radiation therapy together with chemotherapy is
more effective than radiation therapy alone in treating patients with cervical cancer.
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.